Besivance Suspension
Product Images NDC 85766-260

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Besivance (NDC 85766-260). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sportpharm Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (964c5a85 3cc2 4d53 Ab7d F8d205d997e4 01)

Chemical structure of besifloxacin hydrochloride, showing its molecular components including fluorine (F), chlorine (Cl), and a cyclopropyl group, with molecular formula C19H21ClFN3O3·HCl and a molecular weight of 430.30.*

FDA Label Image

1 (Label)

Besivance Besifloxacin Ophthalmic Suspension 0.6% Sterile label with NDC 85766-260-05 for a 5 mL bottle. Distributed by Bausch & Lomb Americas Inc. The label includes batch and lot information placeholders, a QR code, and storage instructions to keep out of reach of children and store at 20-25°C. The label is relabeled for Sportpharm LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.